HKD 20.5
(-3.76%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 15.15 Million USD | -25.7% |
2022 | 20.39 Million USD | 31.23% |
2021 | 15.54 Million USD | -16.44% |
2020 | 18.59 Million USD | -14.6% |
2019 | 21.77 Million USD | 497.87% |
2018 | 3.64 Million USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 63.34 Million USD | 318.12% |
2024 Q2 | 83.68 Million USD | 32.1% |
2023 Q2 | 19.05 Million USD | -6.12% |
2023 FY | 15.15 Million USD | -25.7% |
2023 Q4 | 15.15 Million USD | -9.24% |
2023 Q3 | 16.69 Million USD | -12.39% |
2023 Q1 | 20.29 Million USD | -0.47% |
2022 Q1 | 17.89 Million USD | 15.15% |
2022 FY | 20.39 Million USD | 31.23% |
2022 Q4 | 20.39 Million USD | -2.29% |
2022 Q3 | 20.87 Million USD | 5.5% |
2022 Q2 | 19.78 Million USD | 10.56% |
2021 Q1 | 17.9 Million USD | -3.7% |
2021 Q2 | 18.33 Million USD | 2.4% |
2021 Q3 | 16.96 Million USD | -7.5% |
2021 Q4 | 15.54 Million USD | -8.39% |
2021 FY | 15.54 Million USD | -16.44% |
2020 Q4 | 18.59 Million USD | 0.0% |
2020 Q2 | 18.87 Million USD | 0.0% |
2020 Q1 | - USD | -100.0% |
2020 FY | 18.59 Million USD | -14.6% |
2019 Q3 | 20.85 Million USD | 56.05% |
2019 Q4 | 21.77 Million USD | 4.43% |
2019 Q2 | 13.36 Million USD | 27.7% |
2019 FY | 21.77 Million USD | 497.87% |
2019 Q1 | 10.46 Million USD | 187.29% |
2018 Q4 | 3.64 Million USD | 0.0% |
2018 FY | 3.64 Million USD | 0.0% |
2018 Q2 | 755.67 Thousand USD | 0.0% |
2018 Q1 | 755.67 Thousand USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2015 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 52.86 Million HKD | 71.341% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 99.745% |